Johnson & Johnson Headquarters

Photo: Healthline

Johnson & Johnson Plans To Split Into Two Companies

Healthcare giant Johnson & Johnson announced its plans to split into two different companies on November 12. The company will split its health division that sells Band-Aids and Baby Powder from its large pharmaceuticals unit, reported Reuters. The move came after multinational companies such as Toshiba adopted the same business strategy to simplify their structure. The separation is expected to be completed within 18 to 24 months.

Fri, 12 Nov 2021 - 08:05 PM / by SAM RAHUL RAJASHEKHAR

Tags: Johnson & Johnson, business, Healthcare, Pharmaceuticals

Courtesy: Reuters

Covid-19 Vaccine

Photo: Cheddar

Over 300 COVID Vaccines Under Development, Says WHO

Amidst the ongoing pandemic, pharmaceutical companies are developing over 300 vaccines. Reportedly, 126 and 194 vaccines stand at the clinical development and pre-clinical development stage respectively. India has developed the Covaxin, and is also manufacturing Covishield. According to WHO, few Indian vaccines are in the clinical trial phase. Notably, Bharat Biotech and Thomas Jefferson University have reportedly signed a deal to develop a… read-more

Tue, 19 Oct 2021 - 01:40 PM / by Nehal Surana

Tags: Covid-19, Coronavirus Vaccines, Pharmaceuticals, India, WHO

Courtesy: LiveMint

Representational image

Photo: DNA

NCB Raids Haridwar Based Drug Cartel; Seizes Contraband Worth Rs 30 Lakh

In a big success, the NCB on April 12 seized 70,000 codeine-based cough syrups, opioid pills worth Rs 30.5 lakh and 15 kilograms amphetamine. NCB seized the contrabands from a Haridwar-based pharmaceutical company, allegedly fudged records to export the prohibited items to UK, US and Europe. Receiving orders on Dark-net, the syndicate supplied them in herbal packages. Arresting four, NCB stated to seize the drugs in 34 searches.

Tue, 13 Apr 2021 - 07:44 PM / by Neha Sanjeev

Tags: Drug lord, Drugs, Uttarakhand, Pharmaceuticals

Courtesy: Hindustan Times

Pharma Companies

Photo: AJP

Two Pharma Companies To Invest Rs 700 Crore In Hyderabad's Genome Valley

Hyderabad's Genome Valley will soon be getting new pharmaceutical units with an investment of Rs 700 crore from two city-based drug-makers. The two pharmaceutical companies - Granules India and Laurus Labs - on October 27 announced investments of ₹400 crores and ₹300 crores respectively. Reportedly, the investments aim to create job opportunities for over 1,600 people. Officials from both the companies met Telangana's Industries Minister K.T… read-more

Tue, 27 Oct 2020 - 06:07 PM / by Dharshana Vijayan

Tags: Granules India, Laurus Labs, Hyderabad, Pharmaceuticals, K T Rama Rao

Courtesy: The Outlook